(PRESS RELEASE) COLOMBES, 21-Sep-2022 — /EuropaWire/ — Arkema (EPA: AKE), a French specialty chemicals and advanced materials company and a global leader in PVDF production, has announced that its Pebax® foam and a carbon plate are used by Decathlon’s performance … Read the full press release
Posted in Apparel, Fashion & Beauty, Chemicals, France, Industrial, Sports, Technology
Tagged Arkema, carbon plate, DAVID DUPONT, DECATHLON, KD900X, KIPRUN, Pebax, Pebax® foam, performance running shoe, sports equipment
(PRESSEMITTEILUNG) COLOMBES, 21-Sep-2022 — /EuropaWire/ — Arkema (EPA: AKE), ein französisches Unternehmen für Spezialchemikalien und fortschrittliche Materialien und ein weltweit führendes Unternehmen in der PVDF-Produktion, hat bekannt gegeben, dass sein Pebax®-Schaumstoff und eine Karbonplatte von Decathlons Performance-Laufmarke Kiprun in ihrem … Read the full press release
Posted in Apparel, Fashion & Beauty, Chemicals, France, Industrial, Sports, Technology
Tagged Arkema, Carbonplatte, DAVID DUPONT, DECATHLON, KD900X, KIPRUN, Pebax, Pebax®-Schaum, Performance-Laufschuh, Sportausrüstung
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
